Major Scope

  •  Lung Cancer
  •  Colorectal Cancer
  •  Pancreatic Cancer
  •  Breast Cancer
  •  Prostate Cancer
  •  Liver Cancer
  •  Leukemia
  •  Bladder Cancer
  •  Kidney Cancer
  •  Endometrial Cancer
  •  Oncology Case Reports
  •  Radiation Therapy

Abstract

Citation: Clin Oncol. 2016;1(1):1037.DOI: 10.25107/2474-1663-v1-id1037

Splenectomy Tonsillectomy and Appendectomy - Complications and Cancer Occurrence

Benharroch D, Nalbandyan K, Kraus M, Osyntsov A and Ariad S

Department of Pathology, Soroka University Medical Center and the Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel
Department of ENT, Soroka University Medical Center and the Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel
Department of Surgery B, Soroka University Medical Center and the Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel
Department of Oncology, Soroka University Medical Center and the Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel

*Correspondance to: Daniel Benharroch 

 PDF  Full Text Case Report | Open Access

Abstract:

The removal of secondary lymphoid tissue is not innocuous. Infectious complications in procedures such as total splenectomies are frequent and may be fatal. Sequelae may be thromboembolic. Immune alterations are expected after such procedures. The most controversial consequence, one that is linked with immune changes, is the development of malignant tumors. Regarding post-splenectomy malignancies, there appears to be marked discrepancies between the increased occurrence of tumors in humans and the protective effects seen in experimental animals. It is recommended, that surgeons strive to preserve as much lymphoid tissue as possible.

Keywords:

Cite the Article:

Benharroch D, Nalbandyan K, Kraus M, Osyntsov A, Ariad S. Splenectomy Tonsillectomy and Appendectomy - Complications and Cancer Occurrence. Clin Oncol. 2016; 1: 1037.

Journal Basic Info

  • Impact Factor: 3.231**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
  • PubMed NLM ID: 101705590

Search Our Journal

Journal Indexed In

Articles in PubMed

Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Application of First-Line Steady-State Mobilization vs. Conventional Chemotherapy Mobilization for Peripheral Hematopoietic Stem Cell Mobilization in Newly Diagnosed Multiple Myeloma Patients
 Abstract  PDF  Full Text
Absolute dPCR Quantification of MicroRNAs by Absolute dPCR for the Diagnostic Screening of Colon Cancer
 PDF  Full Text
View More...